Pesticides & Agrochemicals · Founded 1993 · www.bhagirad.com · BSE 531719 · NSE BHAGIRA.CHEM · ISIN INE414D01027
No Notes Added Yet
Business
Bhagiradha Chemicals & Industries Ltd. (BHAGCHEM) is an Indian company primarily engaged in the manufacturing and sale of pesticides and agrochemicals. Its core business involves producing both technical-grade pesticides (active ingredients) and their formulations (finished products ready for application). The company aims to provide solutions for crop protection, helping farmers manage pests, diseases, and weeds to enhance agricultural yield. It makes money by selling these products to distributors, dealers, and directly to farmers across various agricultural regions.
Revenue Mix
While specific revenue contribution data is not provided, the company operates within the broader agrochemicals sector. Typical segmentation for such companies includes:
Technical Grade Products: Manufacturing active ingredients, which can be sold to other formulators or used internally.
Formulations: Producing finished pesticides (insecticides, herbicides, fungicides, plant growth regulators) ready for use by farmers.
Given its nature, BHAGCHEM likely derives revenue from both the production and sale of various types of crop protection chemicals.
Industry
The Indian Pesticides & Agrochemicals industry is characterized by its dependence on monsoon patterns, agricultural policies, and commodity prices. It is a competitive market with numerous domestic and international players. The industry has a mix of large integrated players, mid-sized companies, and smaller regional players. Bhagiradha Chemicals & Industries Ltd. likely positions itself as a mid-tier player, focusing on specific product portfolios or regional strengths within the Indian domestic market, catering to the needs of Indian farmers. Competition often revolves around product effectiveness, pricing, and distribution reach.
MOAT
Bhagiradha Chemicals & Industries Ltd. may possess competitive advantages through:
Backward Integration: If the company manufactures technicals in addition to formulations, it can achieve better cost control and supply chain stability compared to companies reliant solely on imported technicals.
Cost Efficiency: Efficient manufacturing processes for generic agrochemicals can provide a cost advantage in a price-sensitive market.
Distribution Network: A strong, established distribution network in key agricultural regions within India can ensure product availability and market penetration.
Product Portfolio: A focused or diversified portfolio of effective agrochemical solutions catering to prevalent crop issues in specific regions.
Growth Drivers
Key factors that can drive growth for Bhagiradha Chemicals & Industries Ltd. over the next 3-5 years include:
Increasing Food Demand: India's growing population and demand for food will necessitate higher agricultural output, driving demand for crop protection.
Modernization of Agriculture: Adoption of better farming practices and crop protection measures by farmers to improve yield and quality.
Government Support for Agriculture: Initiatives promoting agricultural growth, irrigation, and farmer income can indirectly boost agrochemical demand.
Product Portfolio Expansion: Launch of new, effective molecules or formulations addressing specific pest/disease challenges.
Capacity Expansion: Increasing manufacturing capabilities to meet growing demand or target new markets.
Export Opportunities: Potential to expand sales to international markets, subject to regulatory approvals.
Risks
Monsoon Dependency: The performance of the agricultural sector, and thus agrochemical sales, is heavily reliant on timely and adequate monsoons.
Raw Material Price Volatility: Fluctuations in the prices of crude oil derivatives and other chemical intermediates can impact manufacturing costs and margins.
Intense Competition & Pricing Pressure: The presence of numerous domestic and international players can lead to pricing wars and margin erosion.
Regulatory Changes: Strict environmental regulations, product bans, or changes in pesticide registration processes can impact operations and product viability.
Counterfeit Products: The presence of spurious agrochemicals in the market can erode trust, impact genuine product sales, and damage farmer yields.
Crop Price Volatility: Fluctuating crop prices can affect farmers' purchasing power for agrochemicals.
Management & Ownership
Bhagiradha Chemicals & Industries Ltd. is likely a promoter-driven company, a common structure in India, where the founding family or individuals hold significant ownership and management control. The quality of management is critical in navigating the cyclical and regulated agrochemical sector, requiring expertise in R&D, manufacturing, distribution, and regulatory compliance. Ownership structure typically involves a significant promoter stake, with the remaining shares held by institutional investors and the public.
Outlook
The outlook for Bhagiradha Chemicals & Industries Ltd. presents a balanced view. The company operates in a sector with fundamental demand drivers stemming from India's large agricultural base and the ongoing need for crop protection to ensure food security. Potential tailwinds include increasing agricultural modernization and government support. However, it faces inherent risks such as the unpredictable nature of monsoons, intense competition, and regulatory scrutiny. Success will depend on its ability to manage raw material costs, innovate or efficiently produce effective agrochemical solutions, maintain a strong distribution network, and adapt to evolving agricultural practices and environmental regulations. Continued focus on cost-effective products and market penetration in key agricultural belts would be crucial for sustainable growth.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 111 | 111 | 104 | 103 | 123 | 124 | 140 | 114 | 158 | 195 |
| Other Income | 1 | 2 | 3 | 2 | 1 | 1 | 0 | 1 | 1 | 2 |
| Total Income | 113 | 114 | 107 | 105 | 124 | 124 | 141 | 115 | 159 | 197 |
| Total Expenditure | 97 | 99 | 94 | 94 | 117 | 115 | 125 | 100 | 139 | 164 |
| Operating Profit | 16 | 14 | 13 | 12 | 7 | 10 | 16 | 14 | 20 | 32 |
| Interest | 2 | 1 | 2 | 2 | 2 | 3 | 4 | 3 | 7 | 6 |
| Depreciation | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 8 | 8 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 10 | 8 | 6 | 2 | 3 | 8 | 6 | 5 | 18 |
| Provision for Tax | 3 | 4 | 2 | 2 | 3 | -1 | 2 | 2 | 1 | 4 |
| Profit After Tax | 7 | 6 | 5 | 4 | -1 | 4 | 6 | 5 | 4 | 13 |
| Adjustments | 0 | -0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 |
| Profit After Adjustments | 7 | 6 | 5 | 4 | -1 | 4 | 6 | 5 | 4 | 13 |
| Adjusted Earnings Per Share | 0.1 | 0.5 | 0.4 | 0.3 | -0.1 | 0.3 | 0.4 | 0.4 | 0.3 | 1 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 246 | 318 | 436 | 502 | 408 | 440 | 536 | 607 |
| Other Income | 2 | 1 | 1 | 1 | 3 | 9 | 2 | 4 |
| Total Income | 247 | 319 | 437 | 503 | 410 | 450 | 538 | 612 |
| Total Expenditure | 229 | 271 | 367 | 425 | 365 | 404 | 479 | 528 |
| Operating Profit | 19 | 48 | 69 | 79 | 46 | 46 | 60 | 82 |
| Interest | 5 | 8 | 9 | 5 | 8 | 7 | 17 | 20 |
| Depreciation | 7 | 8 | 9 | 10 | 11 | 14 | 21 | 25 |
| Exceptional Income / Expenses | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 32 | 51 | 64 | 27 | 25 | 21 | 37 |
| Provision for Tax | 2 | 9 | 16 | 19 | 9 | 11 | 3 | 9 |
| Profit After Tax | 7 | 23 | 36 | 45 | 18 | 14 | 18 | 28 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 7 | 23 | 36 | 45 | 18 | 14 | 18 | 28 |
| Adjusted Earnings Per Share | 0.7 | 2.5 | 3.8 | 4.3 | 1.8 | 1.1 | 1.4 | 2.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 22% | 2% | 11% | 0% |
| Operating Profit CAGR | 30% | -9% | 5% | 0% |
| PAT CAGR | 29% | -26% | -5% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -17% | 13% | 26% | 32% |
| ROE Average | 3% | 4% | 10% | 10% |
| ROCE Average | 5% | 6% | 13% | 13% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 132 | 156 | 190 | 313 | 414 | 682 | 698 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 7 | 19 | 10 | 17 | 17 | 30 | 153 |
| Other Non-Current Liabilities | 1 | 3 | 9 | 16 | 20 | 26 | 23 |
| Total Current Liabilities | 83 | 95 | 133 | 101 | 126 | 195 | 246 |
| Total Liabilities | 224 | 273 | 342 | 447 | 576 | 933 | 1120 |
| Fixed Assets | 138 | 152 | 157 | 173 | 214 | 245 | 580 |
| Other Non-Current Assets | 7 | 7 | 11 | 45 | 82 | 313 | 104 |
| Total Current Assets | 79 | 114 | 174 | 228 | 280 | 375 | 436 |
| Total Assets | 224 | 273 | 342 | 447 | 576 | 933 | 1120 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 3 | 0 | 2 | 3 | 10 | 28 |
| Cash Flow from Operating Activities | 48 | 4 | 7 | 14 | 34 | -53 | 12 |
| Cash Flow from Investing Activities | -39 | -21 | -17 | -60 | -116 | -201 | -160 |
| Cash Flow from Financing Activities | -9 | 15 | 12 | 46 | 88 | 272 | 136 |
| Net Cash Inflow / Outflow | 0 | -2 | 2 | 1 | 7 | 18 | -12 |
| Closing Cash & Cash Equivalent | 3 | 0 | 2 | 3 | 10 | 28 | 16 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.69 | 2.46 | 3.77 | 4.34 | 1.75 | 1.07 | 1.4 |
| CEPS(Rs) | 1.39 | 3.32 | 4.69 | 5.28 | 2.81 | 2.14 | 3.02 |
| DPS(Rs) | 0 | 0 | 0.26 | 0.4 | 0.1 | 0.15 | 0.15 |
| Book NAV/Share(Rs) | 13.94 | 16.41 | 20.02 | 30.1 | 31.58 | 52.61 | 53.85 |
| Core EBITDA Margin(%) | 6.89 | 14.75 | 15.67 | 15.4 | 10.53 | 8.39 | 10.66 |
| EBIT Margin(%) | 5.86 | 12.71 | 13.86 | 13.7 | 8.49 | 7.35 | 7.2 |
| Pre Tax Margin(%) | 3.63 | 10.11 | 11.78 | 12.7 | 6.6 | 5.73 | 3.94 |
| PAT Margin (%) | 2.65 | 7.34 | 8.21 | 8.99 | 4.47 | 3.15 | 3.39 |
| Cash Profit Margin (%) | 5.36 | 9.9 | 10.21 | 10.95 | 7.16 | 6.29 | 7.3 |
| ROA(%) | 2.91 | 9.39 | 11.62 | 11.45 | 3.56 | 1.84 | 1.77 |
| ROE(%) | 4.92 | 16.2 | 20.69 | 17.95 | 5.68 | 2.74 | 2.63 |
| ROCE(%) | 8.26 | 20.6 | 24.75 | 21.72 | 8.26 | 5.21 | 4.55 |
| Receivable days | 17.07 | 40.85 | 65.45 | 81.91 | 105.6 | 116.41 | 128.9 |
| Inventory Days | 83.58 | 61.21 | 49.56 | 57.88 | 90.79 | 99.94 | 93.8 |
| Payable days | 56.11 | 64.76 | 67.37 | 66.87 | 93.51 | 105.86 | 127.5 |
| PER(x) | 32.07 | 17.99 | 23.6 | 27.58 | 92 | 260.13 | 122.23 |
| Price/Book(x) | 1.58 | 2.7 | 4.44 | 3.98 | 5.1 | 5.28 | 3.18 |
| Dividend Yield(%) | 0 | 0 | 0.3 | 0.33 | 0.06 | 0.05 | 0.09 |
| EV/Net Sales(x) | 1.01 | 1.51 | 2.11 | 2.57 | 4.24 | 8.31 | 4.54 |
| EV/Core EBITDA(x) | 13.29 | 10.12 | 13.32 | 16.43 | 37.87 | 79.16 | 40.89 |
| Net Sales Growth(%) | 0 | 29.4 | 37.05 | 15.25 | -18.81 | 8.05 | 21.67 |
| EBIT Growth(%) | 0 | 180.5 | 49.45 | 13.88 | -49.68 | -6.5 | 19.18 |
| PAT Growth(%) | 0 | 258.36 | 53.3 | 26.31 | -59.64 | -23.95 | 31.15 |
| EPS Growth(%) | 0 | 258.36 | 53.3 | 15.11 | -59.64 | -38.97 | 31.14 |
| Debt/Equity(x) | 0.32 | 0.4 | 0.42 | 0.16 | 0.19 | 0.12 | 0.33 |
| Current Ratio(x) | 0.95 | 1.2 | 1.31 | 2.27 | 2.23 | 1.92 | 1.78 |
| Quick Ratio(x) | 0.27 | 0.67 | 0.8 | 1.36 | 1.34 | 1.26 | 1.18 |
| Interest Cover(x) | 2.63 | 4.89 | 6.65 | 13.77 | 4.5 | 4.55 | 2.21 |
| Total Debt/Mcap(x) | 0.2 | 0.15 | 0.1 | 0.04 | 0.04 | 0.02 | 0.1 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 20.27 | 20.27 | 20.27 | 19.74 | 19.74 | 19.6 | 19.6 | 19.6 | 19.6 | 19.6 |
| FII | 0.17 | 0.15 | 0.18 | 0.04 | 0.05 | 0.05 | 0.2 | 0.14 | 0.1 | 0.08 |
| DII | 3.14 | 3.14 | 3.08 | 2.89 | 2.89 | 2.89 | 2.99 | 3.02 | 3 | 3.01 |
| Public | 76.42 | 76.44 | 76.47 | 77.33 | 77.31 | 77.46 | 77.22 | 77.24 | 77.31 | 77.31 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.52 | 2.52 | 2.52 | 2.56 | 2.56 | 2.54 | 2.54 | 2.54 | 2.54 | 2.54 |
| FII | 0.02 | 0.02 | 0.02 | 0 | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 |
| DII | 0.39 | 0.39 | 0.38 | 0.38 | 0.38 | 0.38 | 0.39 | 0.39 | 0.39 | 0.39 |
| Public | 9.51 | 9.51 | 9.52 | 10.03 | 10.03 | 10.04 | 10.01 | 10.02 | 10.02 | 10.03 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12.44 | 12.44 | 12.44 | 12.97 | 12.97 | 12.97 | 12.97 | 12.97 | 12.97 | 12.97 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +22% | +2% | +11% | — |
| Operating Profit CAGR | +30% | -9% | +5% | — |
| PAT CAGR | +29% | -26% | -5% | — |
| Share Price CAGR | -17% | +13% | +26% | +32% |
| ROE Average | +3% | +4% | +10% | +10% |
| ROCE Average | +5% | +6% | +13% | +13% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 20.27 | 20.27 | 20.27 | 19.74 | 19.74 | 19.6 | 19.6 | 19.6 | 19.6 | 19.6 |
| FII | 0.17 | 0.15 | 0.18 | 0.04 | 0.05 | 0.05 | 0.2 | 0.14 | 0.1 | 0.08 |
| DII | 3.14 | 3.14 | 3.08 | 2.89 | 2.89 | 2.89 | 2.99 | 3.02 | 3 | 3.01 |
| Public | 76.42 | 76.44 | 76.47 | 77.33 | 77.31 | 77.46 | 77.22 | 77.24 | 77.31 | 77.31 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.52 | 2.52 | 2.52 | 2.56 | 2.56 | 2.54 | 2.54 | 2.54 | 2.54 | 2.54 |
| FII | 0.02 | 0.02 | 0.02 | 0 | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 |
| DII | 0.39 | 0.39 | 0.38 | 0.38 | 0.38 | 0.38 | 0.39 | 0.39 | 0.39 | 0.39 |
| Public | 9.51 | 9.51 | 9.52 | 10.03 | 10.03 | 10.04 | 10.01 | 10.02 | 10.02 | 10.03 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12.44 | 12.44 | 12.44 | 12.97 | 12.97 | 12.97 | 12.97 | 12.97 | 12.97 | 12.97 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.